Community dialogue meetings among district leaders improved their willingness to receive COVID-19 vaccines in Western Uganda, May 2021.

Attitude COVID-19 COVID-19 vaccines District leaders Health behavior Perception Pre-post questionnaire Uganda

Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
26 05 2023
Historique:
received: 08 07 2022
accepted: 16 05 2023
medline: 29 5 2023
pubmed: 27 5 2023
entrez: 26 5 2023
Statut: epublish

Résumé

Widespread COVID-19 vaccine uptake can facilitate epidemic control. A February 2021 study in Uganda suggested that public vaccine uptake would follow uptake among leaders. In May 2021, Baylor Uganda led community dialogue meetings with district leaders from Western Uganda to promote vaccine uptake. We assessed the effect of these meetings on the leaders' COVID-19 risk perception, vaccine concerns, perception of vaccine benefits and access, and willingness to receive COVID-19 vaccine. All departmental district leaders in the 17 districts in Western Uganda, were invited to the meetings, which lasted approximately four hours. Printed reference materials about COVID-19 and COVID-19 vaccines were provided to attendees at the start of the meetings. The same topics were discussed in all meetings. Before and after the meetings, leaders completed self-administered questionnaires with questions on a five-point Likert Scale about risk perception, vaccine concerns, perceived vaccine benefits, vaccine access, and willingness to receive the vaccine. We analyzed the findings using Wilcoxon's signed-rank test. Among 268 attendees, 164 (61%) completed the pre- and post-meeting questionnaires, 56 (21%) declined to complete the questionnaires due to time constraints and 48 (18%) were already vaccinated. Among the 164, the median COVID-19 risk perception scores changed from 3 (neutral) pre-meeting to 5 (strong agreement with being at high risk) post-meeting (p < 0.001). Vaccine concern scores reduced, with medians changing from 4 (worried about vaccine side effects) pre-meeting to 2 (not worried) post-meeting (p < 0.001). Median scores regarding perceived COVID-19 vaccine benefits changed from 3 (neutral) pre-meeting to 5 (very beneficial) post-meeting (p < 0.001). The median scores for perceived vaccine access increased from 3 (neutral) pre-meeting to 5 (very accessible) post-meeting (p < 0.001). The median scores for willingness to receive the vaccine changed from 3 (neutral) pre-meeting to 5 (strong willingness) post-meeting (p < 0.001). COVID-19 dialogue meetings led to district leaders' increased risk perception, reduced concerns, and improvement in perceived vaccine benefits, vaccine access, and willingness to receive the COVID-19 vaccine. These could potentially influence public vaccine uptake if leaders are vaccinated publicly as a result. Broader use of such meetings with leaders could increase vaccine uptake among themselves and the community.

Sections du résumé

BACKGROUND
Widespread COVID-19 vaccine uptake can facilitate epidemic control. A February 2021 study in Uganda suggested that public vaccine uptake would follow uptake among leaders. In May 2021, Baylor Uganda led community dialogue meetings with district leaders from Western Uganda to promote vaccine uptake. We assessed the effect of these meetings on the leaders' COVID-19 risk perception, vaccine concerns, perception of vaccine benefits and access, and willingness to receive COVID-19 vaccine.
METHODS
All departmental district leaders in the 17 districts in Western Uganda, were invited to the meetings, which lasted approximately four hours. Printed reference materials about COVID-19 and COVID-19 vaccines were provided to attendees at the start of the meetings. The same topics were discussed in all meetings. Before and after the meetings, leaders completed self-administered questionnaires with questions on a five-point Likert Scale about risk perception, vaccine concerns, perceived vaccine benefits, vaccine access, and willingness to receive the vaccine. We analyzed the findings using Wilcoxon's signed-rank test.
RESULTS
Among 268 attendees, 164 (61%) completed the pre- and post-meeting questionnaires, 56 (21%) declined to complete the questionnaires due to time constraints and 48 (18%) were already vaccinated. Among the 164, the median COVID-19 risk perception scores changed from 3 (neutral) pre-meeting to 5 (strong agreement with being at high risk) post-meeting (p < 0.001). Vaccine concern scores reduced, with medians changing from 4 (worried about vaccine side effects) pre-meeting to 2 (not worried) post-meeting (p < 0.001). Median scores regarding perceived COVID-19 vaccine benefits changed from 3 (neutral) pre-meeting to 5 (very beneficial) post-meeting (p < 0.001). The median scores for perceived vaccine access increased from 3 (neutral) pre-meeting to 5 (very accessible) post-meeting (p < 0.001). The median scores for willingness to receive the vaccine changed from 3 (neutral) pre-meeting to 5 (strong willingness) post-meeting (p < 0.001).
CONCLUSION
COVID-19 dialogue meetings led to district leaders' increased risk perception, reduced concerns, and improvement in perceived vaccine benefits, vaccine access, and willingness to receive the COVID-19 vaccine. These could potentially influence public vaccine uptake if leaders are vaccinated publicly as a result. Broader use of such meetings with leaders could increase vaccine uptake among themselves and the community.

Identifiants

pubmed: 37237258
doi: 10.1186/s12889-023-15903-5
pii: 10.1186/s12889-023-15903-5
pmc: PMC10213578
doi:

Substances chimiques

COVID-19 Vaccines 0
Vaccines 0

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

969

Subventions

Organisme : PEPFAR
Pays : United States

Informations de copyright

© 2023. The Author(s).

Références

Ann Med Surg (Lond). 2022 Jan;73:103186
pubmed: 34961829
Clin Transl Sci. 2021 Nov;14(6):2200-2207
pubmed: 34213073
Int Q Community Health Educ. 2013-2014;34(1):37-49
pubmed: 24366021
Am J Public Health. 2011 Mar;101(3):465-72
pubmed: 21233436
Mo Med. 2014 Jul-Aug;111(4):344-8
pubmed: 25211867
Healthcare (Basel). 2020 Mar 21;8(1):
pubmed: 32245157
J Community Health. 2021 Apr;46(2):270-277
pubmed: 33389421
Health Policy. 2021 May;125(5):553-567
pubmed: 33820678
Hum Vaccin Immunother. 2021 Oct 3;17(10):3413-3420
pubmed: 34170792
Lancet Infect Dis. 2021 Sep;21(9):1204-1206
pubmed: 34384531
Med Educ. 2004 Dec;38(12):1217-8
pubmed: 15566531
J Med Internet Res. 2021 Mar 9;23(3):e24673
pubmed: 33646966
Health Policy Plan. 2018 Oct 1;33(8):879-887
pubmed: 30084938
Korean J Anesthesiol. 2016 Feb;69(1):8-14
pubmed: 26885295
Patient Educ Couns. 2022 Feb;105(2):277-283
pubmed: 34565643
Pediatrics. 2001 Sep;108(3):661-70
pubmed: 11533333
J Grad Med Educ. 2013 Dec;5(4):541-2
pubmed: 24454995
Patient Educ Couns. 2021 Aug;104(8):1878-1886
pubmed: 33632632
Ther Adv Infect Dis. 2021 Jun 09;8:20499361211024376
pubmed: 34178323
BMC Health Serv Res. 2020 Aug 8;20(1):728
pubmed: 32771022
Glob Health Action. 2017;10(1):1270525
pubmed: 28156196

Auteurs

Edirisa Juniour Nsubuga (EJ)

Uganda Public Health Fellowship Program, Kampala, Uganda. nsubugaeddiej@musph.ac.ug.

Arthur G Fitzmaurice (AG)

United States Centers for Disease Control and Prevention, Kampala, Uganda.

Allan Komakech (A)

Uganda Public Health Fellowship Program, Kampala, Uganda.

Tom Dias Odoi (TD)

Baylor College of Medicine Children's Foundation, Kampala, Uganda.

Daniel Kadobera (D)

Uganda Public Health Fellowship Program, Kampala, Uganda.
Uganda National Institute of Public Health, Kampala, Uganda.

Lilian Bulage (L)

Uganda Public Health Fellowship Program, Kampala, Uganda.
Uganda National Institute of Public Health, Kampala, Uganda.

Benon Kwesiga (B)

Uganda Public Health Fellowship Program, Kampala, Uganda.
Uganda National Institute of Public Health, Kampala, Uganda.

Peter James Elyanu (PJ)

Baylor College of Medicine Children's Foundation, Kampala, Uganda.

Alex Riolexus Ario (AR)

Uganda Public Health Fellowship Program, Kampala, Uganda.
Uganda National Institute of Public Health, Kampala, Uganda.

Julie R Harris (JR)

United States Centers for Disease Control and Prevention, Kampala, Uganda.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH